Record Revenue and EBITDA
Surgery Partners reported full-year adjusted EBITDA growth of 16% and net revenue growth of 13.5%, with the company surpassing $3 billion in revenue and $0.5 billion in adjusted EBITDA for the first time.
Strong Organic and Orthopedic Growth
Same facility revenue grew by 8%, with significant contributions from orthopedic procedures, including a 50% increase in total joint procedures.
Successful Acquisitions and De Novo Growth
The company added seven surgical facilities and opened eight de novo facilities in 2024. The pipeline for 2025 includes 12 facilities in development, supporting long-term growth.
Managed Care and Contractual Rate Confidence
Surgery Partners secured over 99% of expected contractual rates for 2025, with Medicare rate increases of approximately 3%, providing visibility into 2025 rate growth.
Strong Physician Recruitment
The company recruited over 750 new physicians in 2024, enhancing its focus on high-acuity specialties, particularly orthopedics.